Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Jacobio Pharma Receives IND Approval for P53 Y220C Activator JAB-30300 in the U.S. 2024-03-01 14:55
Thermo Fisher Scientific to Inaugurate New Office, Marking Milestone Expansion in Indonesia 2024-03-01 10:30
Innovent Announces First Participant Dosed in a Phase I Study of IBI3002 (an anti-IL-4Rα/TSLP bispecific antibody) in Australia 2024-03-01 08:00
'An Urgent Public Health Necessity' - National Institute for Play Releases New Report Underlining Science and Power of Play 2024-03-01 06:20
uLab® Celebrates One Million Aligner Treatments 2024-03-01 02:42
Metabolon Unveils New Integrated Bioinformatics Platform 2024-02-29 20:58
SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug 'SNB-101' on Pancreatic Cancer 2024-02-29 18:09
Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centricity and Trial Efficiency 2024-02-29 17:40
Hanvon Technology Launches Groundbreaking Fourth-Generation BP Meter Based on Korotkoff Sound Method 2024-02-29 15:13
ANICAV advocate the importance of legumes in the Australian diet as the days get colder 2024-02-29 15:00
Overseas Brand WALOVI of Wanglaoji Made Its Debut Globally to Share the Eastern Health Philosophy with the World 2024-02-29 14:03
Allianz Partners appoints Jacob Fuest as Chief Markets Officer and Board Member 2024-02-29 13:30
Chamlion and 3DRPD Forge Collaboration for Dental 3D Production Center 2024-02-29 11:46
Nin Jiom, Modern Chinese Medicine Pioneer, to Launch NMN Supplement for Healthy Ageing 2024-02-29 11:00
MGI Tech & Juntendo University: Changing the Landscape and Unlocking Answers for Patients with Rare Diseases 2024-02-29 09:00
Huawei Launches the Medical Technology Digitalization Solution to Accelerate Intelligence in Healthcare 2024-02-28 22:14
Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings 2024-02-28 22:03
Skyhawk Therapeutics Has Advanced to the Multiple Ascending Dose Portion of its Phase 1 Study evaluating SKY-0515, a RNA-Targeting Small Molecule for Huntington's Disease 2024-02-28 21:32
RRD International is now RRD Biopharma Development 2024-02-28 21:00
PharmAust announces positive Phase 1 MEND Study Top-Line Results in MND / ALS 2024-02-28 20:47
1 34 35 36 37 38 1508